Home › Funds › CONGRESS ASSET MANAGEMENT CO › LGND
CONGRESS ASSET MANAGEMENT CO position in LGND
LIGAND PHARMACEUTICALS INC · Health Care
CONGRESS ASSET MANAGEMENT CO reported holding 658,556 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$205.7M, representing 1.34% of its reported portfolio and ranking #8 among its reported holdings. CONGRESS ASSET MANAGEMENT CO has disclosed LGND holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR
How CONGRESS ASSET MANAGEMENT CO's LGND position evolved
CONGRESS ASSET MANAGEMENT CO first disclosed a stake in LGND in Q2 2024 at 586,624 shares (US$49.4M). The position peaked in Q2 2026 at 659,911 shares, worth US$208.6M. Across 10 filings, CONGRESS ASSET MANAGEMENT CO increased the stake 7 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 658,556 shares valued at US$205.7M. Notable position changes include a 28% trim in Q4 2025 (shares rose 6% over the following quarter), a 31% increase in Q2 2026 (shares fell 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 586.62K | $49.43M | New |
| Q3 2024 | 604.04K | $60.46M | Add |
| Q4 2024 | 621.48K | $66.59M | Add |
| Q1 2025 | 642.71K | $67.57M | Add |
| Q2 2025 | 647.94K | $73.66M | Add |
| Q3 2025 | 667.31K | $118.21M | Add |
| Q4 2025 | 480.06K | $90.77M | Reduce |
| Q1 2026 | 504.64K | $100.75M | Add |
| Q2 2026 | 659.91K | $208.59M | Add |
| Q3 2026 | 658.56K | $205.71M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LGND and 13F data
LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 57 other funds we track also report a position in LGND — the largest reported positions include Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$150.3M), RICE HALL JAMES & ASSOCIATES, LLC (US$85.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LGND
- Chicago Capital, LLC 551.23K sh · $172.19M · Q3 2026
- Stephens Investment Management Group LLC 475.61K sh · $150.34M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 270.05K sh · $85.36M · Q2 2026
- Ranger Investment Management, L.P. 257.60K sh · $81.42M · Q2 2026
- GW&K Investment Management, LLC 246.88K sh · $78.04M · Q2 2026
- NEXT CENTURY GROWTH INVESTORS LLC 198.54K sh · $62.76M · Q2 2026
- ASHFORD CAPITAL MANAGEMENT INC 170.24K sh · $53.81M · Q2 2026
- Private Capital Management, LLC 166.02K sh · $52.48M · Q2 2026
- VILLERE ST DENIS J & CO LLC 155.51K sh · $49.15M · Q2 2026
- Granahan Investment Management, LLC 147.23K sh · $46.54M · Q2 2026
- Penn Capital Management Company, LLC 100.34K sh · $31.75M · Q2 2026
More on CONGRESS ASSET MANAGEMENT CO
FAQ
How long has CONGRESS ASSET MANAGEMENT CO held LGND?
CONGRESS ASSET MANAGEMENT CO has disclosed LGND holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is CONGRESS ASSET MANAGEMENT CO's current position in LGND?
As of Q3 2026, CONGRESS ASSET MANAGEMENT CO holds 658.56K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $205.71M, representing 1.34% of its reported portfolio and ranking #8.
Has CONGRESS ASSET MANAGEMENT CO been buying or selling LGND?
In the latest 13F filing (Q3 2026), CONGRESS ASSET MANAGEMENT CO held unchanged its position in LGND. The position peaked in Q2 2026 at 659.91K shares.
Which other funds hold LGND?
Other major institutional holders of LGND include Chicago Capital, LLC, Stephens Investment Management Group LLC, RICE HALL JAMES & ASSOCIATES, LLC, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.